Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cadonilimab in combination with radiotherapy for locally advanced cervical cancer patients ineligible for concurrent chemoradi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cadonilimab

Snippet

Sponsor: Ruijin Hospital | Conditions: Locally Advanced Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING